Dimensional Fund Advisors LP Sells 53,494 Shares of Merit Medical Systems, Inc. (MMSI)

Dimensional Fund Advisors LP lessened its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 2.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 2,016,317 shares of the medical instruments supplier’s stock after selling 53,494 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Merit Medical Systems were worth $112,530,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Comerica Bank lifted its position in shares of Merit Medical Systems by 0.6% during the 4th quarter. Comerica Bank now owns 54,289 shares of the medical instruments supplier’s stock valued at $2,897,000 after buying an additional 297 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Merit Medical Systems by 8.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,802 shares of the medical instruments supplier’s stock valued at $212,000 after buying an additional 303 shares during the last quarter. First Mercantile Trust Co. lifted its position in shares of Merit Medical Systems by 7.5% during the 4th quarter. First Mercantile Trust Co. now owns 4,429 shares of the medical instruments supplier’s stock valued at $247,000 after buying an additional 310 shares during the last quarter. Intrust Bank NA lifted its position in shares of Merit Medical Systems by 7.8% during the 4th quarter. Intrust Bank NA now owns 5,016 shares of the medical instruments supplier’s stock valued at $280,000 after buying an additional 363 shares during the last quarter. Finally, Piedmont Investment Advisors Inc. lifted its position in shares of Merit Medical Systems by 3.4% during the 4th quarter. Piedmont Investment Advisors Inc. now owns 13,022 shares of the medical instruments supplier’s stock valued at $727,000 after buying an additional 434 shares during the last quarter. 96.58% of the stock is currently owned by hedge funds and other institutional investors.

A number of research analysts have recently commented on the company. ValuEngine cut Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, April 25th. Needham & Company LLC reaffirmed a “buy” rating on shares of Merit Medical Systems in a research report on Thursday, April 25th. BidaskClub raised Merit Medical Systems from a “sell” rating to a “hold” rating in a research report on Wednesday, May 8th. Finally, Zacks Investment Research raised Merit Medical Systems from a “hold” rating to a “buy” rating and set a $62.00 price target on the stock in a research report on Tuesday, April 30th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $67.80.



Shares of MMSI opened at $56.28 on Wednesday. The stock has a market cap of $3.16 billion, a P/E ratio of 33.30, a P/E/G ratio of 2.45 and a beta of 1.03. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.25 and a current ratio of 2.36. Merit Medical Systems, Inc. has a 52-week low of $47.30 and a 52-week high of $66.34.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Tuesday, April 23rd. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.01. The business had revenue of $238.35 million for the quarter, compared to analysts’ expectations of $236.53 million. Merit Medical Systems had a return on equity of 10.99% and a net margin of 4.68%. The firm’s quarterly revenue was up 17.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.31 EPS. As a group, research analysts expect that Merit Medical Systems, Inc. will post 2.02 EPS for the current year.

In related news, CFO Raul Jr. Parra sold 2,000 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $57.11, for a total transaction of $114,220.00. Following the sale, the chief financial officer now owns 2,000 shares of the company’s stock, valued at approximately $114,220. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kent W. Stanger sold 1,216 shares of the stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $60.54, for a total value of $73,616.64. The disclosure for this sale can be found here. Insiders have sold a total of 43,216 shares of company stock worth $2,579,837 in the last three months. 4.75% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Dimensional Fund Advisors LP Sells 53,494 Shares of Merit Medical Systems, Inc. (MMSI)” was first published by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://dakotafinancialnews.com/2019/05/15/dimensional-fund-advisors-lp-sells-53494-shares-of-merit-medical-systems-inc-mmsi.html.

About Merit Medical Systems

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

Read More: What are the benefits of buying treasury bonds?

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.